Navigation Links
Nuevolution Announces Worldwide Technology Cross-Licensing Agreement With GSK
Date:7/28/2009

nted quantity, quality and speed compared to existing lead discovery technologies.

Nuevolution partners its technology with pharmaceutical and biotechnology companies, and is also developing an internal pipeline by applying Chemetics(R) to validated cancer and cardiovascular targets. Nuevolution has demonstrated the power of Chemetics(R) by identifying highly potent and drug like novel ligands with the potential to address major unmet medical needs across a range of therapeutic areas and target classes.

Nuevolution is a privately owned company and has raised EUR 37 million in financing from key Scandinavian investors, including SEB Venture, Sunstone Capital, SLS Invest and Novo A/S. For more information about Nuevolution A/S, please visit the company's website http://www.nuevolution.com

    For further information please contact:

    Nuevolution A/S
    Alex Haahr Gouliaev, CEO
    T: +45-70-20-09-87
    ahg@nuevolution.com



'/>"/>
SOURCE Nuevolution A/S
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Nuevolution Announces Progress in Its Collaboration With Merck & Co. Inc.
2. Nuevolution Announces Research and Development Collaboration with Merck & Co. Inc.
3. Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals
4. SEQUENOM Announces Launch of MassARRAY Compact 96 System
5. Human Genome Sciences Announces Proposed Public Offering of Common Stock
6. Webcast Alert: Neurocrine Biosciences Announces 2nd Quarter 2009 Earnings Results
7. Sechrist Industries, World Leader in Hyperbaric Chambers, Announces Edward Pulwer as President/CEO
8. Orexigen(R) Therapeutics Announces Full Exercise of Overallotment Option by Underwriters
9. PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group
10. Spectrum Announces Fetal Bovine Serum Product Line
11. Cell Therapeutics, Inc. Announces Exercise of Overallotment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 31, 2015   Mapi expands Pharmacovigilance ... Affairs and global Risk Management strength with the ... announced acquisition . Pharmacovigilance ... a global team that includes physicians, pharmacists, and ... experience in navigating complex safety requirements throughout the ...
(Date:3/31/2015)... 2015 This June 13th, a distinguished ... U.S and International Medical Schools will come together in ... the application of stem cell therapy in treatments and ... and funded by the Ocular Research Symposia Foundation, ... convening intimate meetings of top experts in the field ...
(Date:3/30/2015)... 2015 With recent advancements in residential ... government, major companies are getting into the Solar Energy ... mandates for renewable energy production, many homeowners are looking ... Power is a new solar distribution company in California ... allow qualifying homeowners to enjoy the benefits of solar ...
(Date:3/30/2015)... March 30, 2015  NuGene International, Inc. ("NuGene") ... NuGene BioPharma, Inc. has added another internationally recognized ... Guan is an internationally recognized researcher in bio-inspired ... education at Peking University, China ... the University of North Carolina, Chapel Hill. Following ...
Breaking Biology Technology:Mapi expands Pharmacovigilance and Risk Management capabilities 2Mapi expands Pharmacovigilance and Risk Management capabilities 3Sight Restoration Through Stem Cell Therapy - Subject of June Symposium of Experts 2Solara Power Announces Residential Solar Power with No Up-Front Fees 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 3
... 12 ,Abbott ( NYSE: ABT ) and Advanced Medical Optics ... for Abbott to acquire AMO for $22 per share in,cash, ... estimated net debt at the time of closing. Based ... care, comprised of three segments: cataract,surgery, laser vision correction (LASIK), ...
... NEW YORK, Jan. 12 /PRNewswire-Asia-FirstCall/ -- American Oriental,Bioengineering, ... "the Company"), a leading marketer,distributor and manufacturer of ... the Company will attend and undertake one-on-one,meetings at ... the Pudong,Shangri-La hotel in Shanghai. Management is ...
... at 27th Annual J.P. Morgan Healthcare Conference -REDWOOD CITY, ... GHDX ) announced today that it has initiated ... DX(R) colon cancer assay. Utilizing more than 1,200 ... study will use prospectively defined endpoints to assess the ...
Cached Biology Technology:Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 2Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 3Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 4Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 5Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 6Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 7Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay 2Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay 3Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay 4Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay 5
(Date:3/12/2015)... WINSTON-SALEM, N.C. , March 12, 2015 ... afternoon at Brenner Children,s Hospital, part of Wake Forest ... an outreach initiative for the 2015 ACC Men,s Basketball ... taking pictures with them and getting their autographs. ... Wake Forest Baptist. It is the only children,s hospital ...
(Date:3/11/2015)... DUBLIN , Mar. 11, 2015 Research and ... addition of the "Access Control Market by Product, ... to 2020" report to their offering. , ... is expected to reach $10.4 billion by 2020, with ... control market report covers the products types such as ...
(Date:3/10/2015)... , March 10, 2015 ... "Personalized Medicine in Human Space Flight" ... Thomas J. Goodwin , Ph.D. was recently featured ... the past two years. Specifically, "Personalized Medicine ... downloaded scientific papers published in 2013 and 2014 from ...
Breaking Biology News(10 mins):Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2"Personalized Medicine in Human Space Flight" Listed Among Most Influential Papers of 2013 and 2014 2
... University, in London, Canada, have developed a CT (Computed Tomography) ... Battista, Chair of the Department of Medical Biophysics at the ... the London Regional Cancer Program at London Health Sciences Centre ... interactive way to teach CT imaging techniques to a wide ...
... Research Institute (OHRI) and the University of Ottawa (uOttawa) has ... (CIHR) and $75,000 from the Stem Cell Network to lead ... cell therapy for septic shock. This deadly condition occurs when ... system, resulting in severe organ damage and death in 30 ...
... Epigenetics is the new hip science. Time Magazine,s front cover ... explains why. Its more explicit subtitle provided the hook - ,The ... change your genes - and those of your kids,. Who ... ways in which the genetic code in our DNA is regulated ...
Cached Biology News:Mini-CT scanner developed as a teaching tool 2Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock 2Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock 3Epigenetics and epidemiology -- hip, hype and science 2Epigenetics and epidemiology -- hip, hype and science 3
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3...
Low melting point. Ideally suited for in gel enzymatic reactions. Gelling temp. 24-28C Melting temp. 65C. EEO 0.12 Resolution 0.5-20 kb; Rnase/Dnase: none detected....
...
QPRT Immunogen: QPRT (NP_055113, 198 a.a. ~ 298 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Biology Products: